200 related articles for article (PubMed ID: 16480168)
1. A retrospective chart review comparing tiagabine and benzodiazepines for the treatment of alcohol withdrawal.
Myrick H; Taylor B; LaRowe S; Nguyen S; Boyle E; Cochran K; Malcolm R
J Psychoactive Drugs; 2005 Dec; 37(4):409-14. PubMed ID: 16480168
[TBL] [Abstract][Full Text] [Related]
2. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
3. For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.
Oulis P; Masdrakis VG; Karapoulios E; Karakatsanis NA; Kouzoupis AV; Papadimitriou GN
Psychiatry Clin Neurosci; 2009 Feb; 63(1):122. PubMed ID: 19154218
[No Abstract] [Full Text] [Related]
4. Intensity of symptoms from alcohol withdrawal in alcohol-dependent patients: comparison between smokers and non-smokers.
Jacques D; Zdanowicz N; Reynaert C; Janne P; Timary P
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S123-5. PubMed ID: 21894118
[TBL] [Abstract][Full Text] [Related]
5. An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects.
Paparrigopoulos T; Tzavellas E; Karaiskos D; Malitas P; Liappas I
J Psychopharmacol; 2010 Sep; 24(9):1375-80. PubMed ID: 19346278
[TBL] [Abstract][Full Text] [Related]
6. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
Nuss MA; Elnicki DM; Dunsworth TS; Makela EH
W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
Huang MC; Chen CH; Pan CH; Lin SK
J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
[TBL] [Abstract][Full Text] [Related]
8. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.
Melby K; Gråwe RW; Aamo TO; Salvesen Ø; Spigset O
Drug Alcohol Depend; 2019 Apr; 197():95-101. PubMed ID: 30784955
[TBL] [Abstract][Full Text] [Related]
9. GABA systems, benzodiazepines, and substance dependence.
Malcolm RJ
J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
[TBL] [Abstract][Full Text] [Related]
10. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.
Malcolm R; Myrick H; Roberts J; Wang W; Anton RF; Ballenger JC
J Gen Intern Med; 2002 May; 17(5):349-55. PubMed ID: 12047731
[TBL] [Abstract][Full Text] [Related]
11. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
[TBL] [Abstract][Full Text] [Related]
12. Tiagabine withdrawal-emergent mania.
Pushpal D; Shamshul HN
Aust N Z J Psychiatry; 2006 Aug; 40(8):719. PubMed ID: 16866771
[No Abstract] [Full Text] [Related]
13. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital.
Hecksel KA; Bostwick JM; Jaeger TM; Cha SS
Mayo Clin Proc; 2008 Mar; 83(3):274-9. PubMed ID: 18315992
[TBL] [Abstract][Full Text] [Related]
14. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
[TBL] [Abstract][Full Text] [Related]
15. Baclofen for alcohol withdrawal.
Liu J; Wang LN
Cochrane Database Syst Rev; 2013 Feb; (2):CD008502. PubMed ID: 23450582
[TBL] [Abstract][Full Text] [Related]
16. Oxazepam versus clomethiazol in alcohol withdrawal treatment.
de Millas W; Ganzer F; Kuhn S; Haasen C
Eur Addict Res; 2010; 16(4):179-84. PubMed ID: 20606442
[TBL] [Abstract][Full Text] [Related]
17. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis.
Pribék IK; Kovács I; Kádár BK; Kovács CS; Richman MJ; Janka Z; Andó B; Lázár BA
Drug Alcohol Depend; 2021 Mar; 220():108536. PubMed ID: 33503582
[TBL] [Abstract][Full Text] [Related]
20. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
